BiotechTube
Imagene AI

Imagene AI

New York, United States· Est.
imagene-ai.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1M

Overview

Imagene AI, founded in 2020, is a private, early-revenue stage company developing a proprietary Cross-Modality Intelligence Engine for precision oncology. Its SaaS platform, the Oncology Intelligence (OI) Suite, leverages AI on histopathology images and multimodal data to accelerate biomarker discovery, patient stratification, and trial optimization. The company has established key partnerships with industry leaders like Tempus and Oracle Cloud Infrastructure to deploy its technology, positioning it at the intersection of AI diagnostics and biopharma R&D.

Oncology

Technology Platform

Proprietary Cross-Modality Intelligence Engine using foundation models and LLMs to analyze and integrate histopathology imaging, molecular data (gene expression, mutations), and clinical records for precision oncology insights.

Funding History

1
Total raised:$1M
Seed$1M

Opportunities

The company addresses the critical need for faster, more insightful oncology decision-making by reducing biomarker testing turnaround from weeks to days.
Its platform also taps into the growing demand from biopharma to improve clinical trial success rates through better patient stratification and biomarker discovery.
Strategic partnerships with major players like Tempus and Oracle provide significant channels for scaling and market penetration.

Risk Factors

Key risks include the need for extensive clinical and regulatory validation of its AI models as medical devices.
The company operates in a highly competitive landscape with well-funded AI pathology and data analysis rivals.
Its success is also dependent on integrating into complex, established clinical workflows and securing broad adoption beyond initial partnerships.

Competitive Landscape

Imagene AI competes in the rapidly growing AI-powered digital pathology and multimodal data integration space. Direct competitors include companies like Paige.AI, PathAI, and Reveal Biosciences, which also analyze histopathology images. It also faces competition from large diagnostic firms (e.g., Roche, Philips) developing their own AI solutions and from biopharma companies building internal capabilities.

More companies in AI / Machine Learning →More companies in United States →